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NIGERIAN WOMEN LIVING IN THE UNITED STATES ARE MORE HIRSUTE THAN THOSE 
LIVING IN NIGERIA 
Kikelomo Olorunrinu   
 Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven , CT 
06515 
This study was to determine if there exists a difference in the rate of hirsutism in genetically 
similar women in two different environments. 112 Nigerian women living in the U.S.A and 70 women 
living in Nigeria were surveyed. All women completed a pictorial survey scoring peripheral hair growth in 
6 body areas from 0 (no significant hair growth) to 4 (severe hair growth). Total hirsutism score was 
calculated as a sum of individual scores. The survey also included demographic data, menstrual history, 
and data regarding use of hormonal treatments. Statistical comparisons between groups included t-test, 
nonparametric tests and chi-square test. Multiple regression analysis was carried out to identify 
independent predictors of peripheral hair growth. Women residing in U.S.A had a 31% higher total 
hirsutism score than those residing in Nigeria. This difference was not related to irregular menstrual cycle. 
To account for possible effects of age, B.M.I and differences in tribal origin, multiple regression analysis 
was performed. Location (living in U.S.A vs. Nigeria) remained the strongest predictor of total hirsutism 
score (P=0.02); tribal origin was also significant (P=0.04), while age and B.M.I had no independent 
predictive value (P>0.1). It was concluded that this difference, is not explained by factors such as age, 
obesity and ethnic origin. We propose that this difference may be due to differences in environmental or 
lifestyle factors of the women. 
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Background 
Hirsutism is defined as the presence of terminal (coarse) hairs in females in a 
male-like pattern caused primarily by androgen excess  1,  2.  Non-androgenic causes of 
hirsutism are rare and include acromegaly, Cushing’s syndrome, and certain drugs 1. 
Androgenic causes account for approximately 75-80% of hirsutism cases.  Regardless of 
the etiology of hirsutism, it is a constant psychosocial and aesthetic problem for the 
individual involved, in addition to the medical implications 
Hair growth patterns are thought to be heritable, and hirsutism in particular with 
the corollary of PCOS is thought to be familial. In addition, body hair growth patterns 
differ across racial divides and even ethnic groups 2. Consequently, in order to study the 
prevalence of hirsutism, it is necessary to evaluate genetically similar individuals, that is, 
distinct ethnic/ geographic groups so as to remove confounding variables.  The degree of 
hirsutism is determined by a scoring system devised by Ferriman and Gallwey in 1961 3. 
In their landmark paper of 1961, they scored 12 body parts of in a group of Caucasian 
women. They defined hirsutism as a score of 8 or more.  Several modifications have been 
proposed including one by Hatch et al 4. A score of 6 or above on the modified Ferriman-
Gallwey scale is required for a diagnosis of hirsutism 1. Of recent, even a score above 3 is 
considered by statistical methods to be abnormal in a population study involving black 
and white women 5. Not all women with unwanted or excess facial hair have hirsutism of 
identifiable cause. This type of hirsutism is termed ‘idiopathic’ 1. However, Souter et al 
in 2004 found that even in women who do not meet the criteria for hirsutism, that is, with 
a score between 1 and 5 on a modified Ferriman-Gallwey scale, PCOS was observed in 
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50% of the study participants 2. Thus, unwanted hair in a population of women should not 
be treated lightly as it may actually be of clinical significance.  The scale was revised by 
Hatch et al in 1981 to include the parts of the body most sensitive to androgens6.  
Hirsutism is the most commonly used clinical criterion for the diagnosis of 
hyperandrogenism 8. It affects between 5-15% of women depending on definition and the 
way it is measured 1. According to the 2005 estimate of the U.S.A census bureau, there 
are about 62 million women of reproductive age living in the United States 9, 6. This 
means that between 3 and 9 million American women are affected. About half of these 
women also have underlying hyperandrogenism 8. Conversely 70-80% of women with 
hyperandrogenism will have hirsutism 2, 6.  
Using the Hatch modified scale, with hirsutism defined as a score of 6 and above, 
8% of the subjects had hirsutism in a prospective study involving 369 hirsute women10.  
Even in women with minimal hair growth, that is, a modified Ferriman-Gallwey (mF-G) 
score of 5 or less, up to 60% demonstrated hyperandrogenism, including some 
eumenorrheic subjects. One study found that statistically, working with mF-G scores of 
633 black and white women in a multicenter study, a score of 3 or greater could be 
considered abnormal. Therefore a cut-off of 6 is not inappropriate 1.  
Attempts have been made to derive a population definition of hirsutism. Patterns 
of hair growth differ from one ethnic group or race to another. Questions have been 
raised about the validity of having a one-size-fits-all all approach to defining hirsutism 
across race and ethnicity since the density of hair follicles and rate of hair growth varies 
by ethnicity 8. Caucasians have the highest density of hair follicles per unit area, followed 
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by blacks then Asians.  Consequently, racial and ethnic differences in the rates of 
hirsutism also exist 11.  For instance, Asian women may present with biochemical 
hyperandrogenemia, without obvious dermatologic manifestation of androgen excess 8. 
The phenotypic expression of hyperandrogenism as hirsutism in females of Asian 
extraction is not as common or pronounced as in black and Caucasian females1. Only 
20% of Japanese women with PCOS 11 exhibit hirsutism as opposed to 70-80% in blacks 
and whites 1. Southern European, Mediterranean and Middle Eastern women have a 
genetic predisposition for some facial hair growth 8.Generally, in Nigeria, Ibo women are 
known to have increased body hair.  
 
              Physiology of hair growth 
The unit of hair growth in the body is the pilosebaceous unit (P.S.U). The P.S.U is 
an epidermal appendage programmed from the embryonic stage to develop into a 
sebaceous gland or hair follicle 12. Its structure is depicted in Figure 1. In humans, they 
are fully formed in the embryo at between 2 and 4 months in utero. The human body has 
two categories of hair types: sexual and non- sexual.  Sexual hair is found in axillary, 
pubic, perineal, genital, upper lip and beard areas. Most facial P.S.Us in females are 
programmed to become sebaceous glands. Non sexual hair is found on the scalp, 
eyebrows, arms and legs. Hair also exists in three forms on the body: terminal, vellous 
and lanugo 8, 1. 
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Figure 1. Anatomy of a pilosebaceous unit containing a terminal hair follicle. (Reprinted with permission from Sanchez LA, Perez M, 
and Azziz R. Laser hair reduction in the hirsute patient: A critical assessment. Hum Reprod 2002;8:169–81. ©European Society of 
Human Reproduction and Embryology. Reproduced by permission of Oxford University Press/Human Reproduction.) Azziz. 
Hirsutism. Obstet Gynecol 2003. 
 
Terminal hair is thick, pigmented, coarse, medullated and found on the scalp, eyebrows, 
pubis and axilla.  Vellous hair is fine, non-medullated, non pigmented hair found on the 
apparently hairless parts of the body.  Lanugo is soft, unmedullated hair on the surface of 
the fetus which is shed peri-partum 1.  In the pre-pubertal state in man, sexual hair exists 
in the vellous form. At puberty, under the influence of androgens, vellous hairs in sexual 
areas become terminal hairs. This important role of androgens was discovered in 1950 by 
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Hamilton, who found that males castrated before puberty did not develop axillary hair 
and beards while castration after puberty led to regression or reduction in axillary hair 
and beards 13.  
Hair follicles go through 3 stages in their life cycle: anagen is the stage of active 
growth and elongation; catagen is the shortening and transition stage between anagen and 
telogen; and telogen is the resting stage when the hair is shed 1, 12, 14. The rate of hair 
growth depends on the duration of anagen, the percentage of time spent in anagen, the 
linear elongation rate of the hair follicle, the diameter of the hair (medullated hair is 
thicker than vellous; genetics also plays a role in hair thickness) and density of P.S.Us.  
The role of Androgens on the P.S.U 
The growth and development of hair of sexual hair is largely dependent on 
androgens. Androgens are the most important determinant of the distribution of the 
different types of hairs on the body 1 (Figure 2 and Table 1). Testosterone and 
dihydrotestosterone (DHT) act on the androgen receptors (AR) found on the dermal 
papillae of the P.S.U to effect growth of the hair follicle 12, 14. ARs belong to the steroid 
receptor family. They are ligand activated nuclear receptors with a DNA binding and 
ligand binding domains. Ligand binding leads to a conformational change in the receptor 
which leads to mRNA transcription.  
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Table 1. Distribution of terminal hair under endocrine conditions. From Stanczyk FZ. Diagnosis of hyperandrogenism: Biochemical 
criteria. Best Practice & Research Clinical Endocrinology & Metabolism. 2006;20(2):177-91.  
Androgens not only increase the duration of time spent in anagen 14, they also 
cause the medullation of vellous hair follicles, converting them to terminal ones. This 
process may take months to years of androgen exposure 8. Since interaction of androgens 
and AR is necessary for conversion of vellous hair to terminal hair, it follows that 
hirsutism in females could be due to increased levels of androgens or increased AR 
sensitivity to androgens. 8. Paradoxically, under androgenic influence, scalp hair 
undergoes regression of vellous hair in men and women so genetically predisposed. 
Androgens also lead to enlargement and development of sebaceous glands leading to 
copious secretion of sebum. As such, the holy trinity of androgen excess in females is 
acne, hirsutism and male pattern alopecia 15, most likely in that order depending on how 
elevated androgen levels are. The effects of androgen on hair growth in humans proceeds 
in a caudal-cephalad fashion with increasing levels of androgen 12, 14. Figure 2 shows the 
stages of sexual hair development as it corresponds to increasing plasma T in the 
developing male.   
It follows that rising levels of androgen in females would cause undifferentiated 
hair on the face, chest etc to undergo medullation and become sexual hair (see Figure 3). 
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Hyperandrogenism is diagnosed by measuring plasma free testosterone (T) derived from 
plasma total testosterone and SHBG. The higher the level of SHBG is, the lower the level 
of free T. The normal level of total T is 20-70ng/dl and free testosterone is 1-8pg/ml 15. 
Routine testing for other androgens is of little clinical value in the evaluation of hirsutism 
except maybe to diagnose androgen secreting tumors and to confirm clinical suspicion of 
hyperandrogenism 16.  
 
 
Figure. 2. Relationship of stages of sexual hair development to testosterone as a representative plasma androgen. Note logarithmic 
scale for testosterone. A, Prepubertal; B, stage 3 pubic hair; C, stage 5 pubic hair; D, moderate hirsutism; E adult male. From  R. L. 




Four principal androgens are secreted by the endocrine glands: 
dehydroepiandrosterone sulfate (DHEAS), Dehydroepiandrosterone (DHEA), 
androstenedione, and testosterone (T). These androgens are formed by well established 
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pathways in the ovaries and the adrenals as depicted in the figures below (Figure 4a and 
4b). Almost all of the DHEAS produced in a woman is produced by the adrenals; the rest 
comes from the ovaries. It is the most abundant androgen in the human female 15. 
Contributions of the two glands to androgen production are shown in Table 2. T and 
DHT are carried in the blood unbound or bound to sex hormone binding globulin 
(SHBG) while DHEAS and DHEA and adrostenedione are bound to albumin 15.  Only 1-
2% of T and DHT in the body is unbound. This is the fraction available for biologic 
action 12.  
Androgen Ovary Adrenals 
DHEA 20% 80% 
DHEAS 0% ~100% 
Androstenedione 50% 50% 
Testosterone (T) 50-66% 33-50% 
Table 2. Percentage contributions to the four major androgens from the ovary and the adrenals 15. 
Androgens can also be synthesized in the P.S.U itself 12. In fact, skin is a major 
site of testosterone formation in the female 14.  DHEAS, DHEA and androstenedione are 
converted to T in the skin. The most potent androgen in the body, dihydroteststerone 
(DHT), is formed in skin from T or androstenedione by 5α- reductase (Figure 3 and 4b) 
15. The high potency of DHT is due to a higher affinity for the AR than T 14.            
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 5α- reductase is a microsomal NADPH dependent enzyme with 2 isozymes. Type 
2 is important for most androgen actions in sexual organs and deficiency results in male 
pseudohermaphroditism. The type 1 is the major isozyme in skin 14.   
 
Figure 3. Effects of circulating androgens on cutaneous hair growth. From Azziz R, Carmina E, Sawaya ME. Idiopathic Hirsutism. 




Figure 4a. Scheme of andrenal seroidogenesis. From New MI. Nonclassical 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 
2006 November 1, 2006;91(11):4205-14 
  





Figure 4b. Synthesis of  T and DHT from DHEAS and DHEA, also showing metabolism of T and DHT to glucuronides. 
Hairs from balding scalp have more ARs in the dermal papilla than hair from non- 
balding scalp 12. Therefore, the dermal papilla may be responsible for the effects of 
androgens on the P.S.U.  
The biologic effects of androgens are determined by the rate of metabolism or 
degradation to less androgenic compounds. At the site of action, for instance, testosterone 
is converted to estrogen in the hair follicle by aromatase. The heterogenicity of cutaneous 
manifestation of androgen excess has been attributed to differences in metabolism of 
androgens at the P.S.U and differences in AR sensitivity to androgens 12.   
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Table 3. Average plasma levels of the major androgens and testosterone binding globulin (TEBG) in normal and hirsute individuals 
Table 3 indicates that hirsute women seem to have higher levels of androgen and 
androgen concentration. Women with cryptic hyperandrogenism, that is, high levels of 
androgens and no cutaneous manifestation may have higher rates of androgen 
metabolism, degradation and inactivation, or less sensitive ARs.  Women with normal 
androgen levels and hirsutism may have hypersensitive ARs, or slow/impared 
metabolism/degradation of androgens. There is also the possibility that hirsute women 
convert T to DHT at a higher rate. Stancyzyk et al carried out a series of studies testing 
this hypothesis by measuring 5α reduced metabolites in serum and skin. They found that 
levels of 3α –androstanediol and androsterone conjugates were higher in hirsute women 
than in normal women 15.  Furthermore, the conversion rates of T to DHT and T to 3α –
androstanediol in genital skin of hirsute women is intermediate between than for normal 
women and men. Serum levels of 3α –androstanediol glucuronide was also found to be 
elevated in hirsute women 14. Whereas, men and non-hirsute women express 
predominantly type 2 isozymes of 5α- reductase in genital skin, hirsute women seem to 
express predominantly type 1 isozymes 15.  These findings have been countered by other 
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researchers who say that androgen conjugates are more likely a marker of adrenal steroid 
production than skin metabolism 14. Nevertheless, whether elevated levels of conjugates 
are due to differential skin metabolism of androgens in the skin, or increased 
steroidogenesis from the adrenals, the fact remains there is a measurable difference. 
Effects of Non‐androgenic Hormones on the P.S.U 
Growth Hormone (GH), insulin, glucocorticoids and estrogen may play a role in 
P.S.U growth in man. Growth hormone seems to be synergistic with androgens in 
promoting hair growth and is probably responsible for the hirsutism seen in acromegalic 
patients. In addition, the waxing and waning of acne during adolescence corresponds 
more to the rise and waning of GH than androgens 14. Furthermore, Zachmann and Prader 
17 showed that GH deficient boys are sub-normally responsive to T (Figure 5). Sex 
hormones also stimulate the production of GH. The growth hormone spike during 
puberty is due to a response to rising estrogen/testosterone levels 18. Stress and exercise 
are also known to stimulate release of GH. GH is diabetogenic; increasing the rate of 
lipolysis, thereby increasing levels of free fatty acids and also raising insulin levels 18. 
IGF-1 is thought to potentiate the effects of GH. 
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Figure 5 .Comparison of the total cumulative testosterone dose needed to induce axillary hair growth in 23 boys with and without GH 
deficiency. The mean total dose of testosterone (lines in figures) needed to induce axillary hair growth was significantly higher in the 
GH-deficient group as compared with the non-GH-deficient group. The open circles represent two patients who did not develop 
axillary hair despite 2.2 and 3.7 yr of testosterone treatment  from M. Zachmann and A. Prader: J Clin Endocrinol Metab 30:85–95, 
1970 (181). © The Endocrine Society. 
Insulin’s effects on the P.S.U is evidenced by the fact that hair growth can be 
accelerated in DM I sufferers when insulin is supplemented. Insulin acts as a growth 
factor in keratinocytes or dermal fibroblasts cells, hence the development of acanthosis 
nigricans in hyperinsulinemic, insulin resistant states 11. Moreover, insulin deficient hair 
follicles enter a premature catagen phase in vitro. 14 
Cortisol, a glucocorticoid, also seems to have an effect on the P.S.U because 
Cushing’s syndrome may result in hypertrichosis 19.  
The role of estrogens in P.S.U growth and development is largely unclear. 
Estradiol is thought to weakly inhibit 5α reductase. Hairs from balding areas of scalp 
have less aromatase than hairs from non-balding areas of scalp. Furthermore, a condition 
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known as telogen effluvium, in which several hairs simultaneously enter telogen is 
common after pregnancy or after withdrawal of oral contraceptives 12,14. Paradoxically, 
pubic hair increases in hypogonadal females when puberty is induced by physiologic 
doses of estradiol alone 14 
Other hormones that may play a role in P.S.U growth include prolactin and 
thyroid hormone. Prolactenemia is marked by hirsutism which may be mediated by 
increased adrenal androgen production. Hyperthyroidism leads to diffuse hair loss and 
hypothyroidism leads to dry and brittle hair. 
Differential Diagnosis of Hirsutism 
Hirsutism should be distinguished from hypertrichosis. Hirsutism is specifically in 
a male pattern and involves excessive sexual hair. Hypertrichosis is generalized excessive 
hair growth that may be due to therapeutic drugs such as glucocorticoids, phenytoin, 
minoxidil or cyclosporine. Other causes include metabolic diseases such as anorexia 
nervosa and physical irritation of skin. These changes are not due to androgen excess 16. 
Moreover, the resulting hair is usually vellous 1.  
The causes of hirsutism can be divided into three categories: non androgenic 
causes, those due to androgen excess, and idiopathic hirsutism. The most common 
hyperandrogenic cause of hirsutism in women of reproductive age is polycystic ovarian 
syndrome (PCOS) but its diagnosis is primarily one of exclusion. PCOS accounts for 70-
80% of cases of hirsutism 11. In fact PCOS is almost synonymous with hirsutism and 
hyperandrogenism in women21.  
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Other androgenic causes include non-classic adrenal hyperplasia (NCAH), 
androgen secreting tumors, hyperandrogenic, insulin resistance and acanthosis nigricans 
(HAIRAN) syndrome, Cushing’s syndrome, androgenic or therapeutic drug intake and 
hyperprolactinemia 8,1. In a study involving 873 patients with signs of androgen excess, 
Azziz et al found that the prevalence of androgen secreting tumors was 0.23%, CAH 
0.69%,  NCAH 1.06%, HAIRAN 3.78%, idiopathic hirsutism 4.68%, hyperandrogenism 
with hirsutism 6.75%, and PCOS 82.02% 21. 
 NCAH, a mild form of adrenal hyperplasia caused by a mutation on the CYP21 
gene resulting in 21β-hydroxylase deficiency, results in accumulation of the precursors  
progesterone and 17 hydroxyprogesterone. These are ultimately converted to 
androstenedione leading to hyperandrogenism (see Figure 4a) 22, 23.  In the U.S.A, the 
disorder affects 0.05-0.1% of the general population and 1-10% of hyperandrogenic 
women with the highest incidence in Ashkenazi Jews, 1:27 22,23. The data on NCAH on 
blacks is quite sparse, but the incidence of NCAH in blacks seems to be less than in 
whites 24. The classic form of adrenal hyperplasia presents at birth with virilized genitalia 
in the female, or impaired aldosterone synthesis. With NCAH, females are asymptomatic 
at birth but develop symptoms related to androgen excess later in life. Symptoms include 
premature pubarche, accelerated linear growth, advanced bone age, short adult height, 
severe cystic acne, temporal baldness, infertility, menstrual irregularities, an ovulation 
and hirsutism. In a study of 28 women with known NCAH, 39% had isolated hirsutism 23.   
HAIRAN syndrome is characterized by ovulatory dysfunction, insulin resistance, 
hyperinsulinemia and hyperandrogenism. Affected individuals also have acanthosis 
nigricans, a cutaneous marker for insulin resistance characterized by increased growth of 
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the epidermal layer in skin folds such as the back of the neck, the ante-cubital, groin and 
axillary areas. The lesions are thickened, rough, and velvety gray-brown. This condition 
is linked to the metabolic syndrome, obesity, diabetes mellitus type II and increased 
cardiovascular risk. 11. Diagnosis is made by clinical and laboratory criteria:  fasting 
glucose and insulin levels, glucose tolerance tests and androgen level assays 1.  
Androgen secreting tumors are generally very rare in women with hirsutism, 
between 1/300 to 1/1000 hirsute women 1.  Serum androgen levels tend to be very high 
(total T> 150ng/l or DHEAS > 8000ng/l) and ultrasound or physical exam finding of 
pelvic or abdominal mass should raise a high suspicion for tumor.   
Other conditions that need to be ruled out in hirsutism include thyroid 
dysfunction, use of exogenous steroids or contact with persons who use exogenous 
steroids, prolactinemia and acromegaly. Other possible sources of exposure to androgens 
involve the use of topical androgen preparations possibly by partners of the opposite sex. 
Virilization in pre-pubertal girls from exposure (by passive contact) to topical androgen 
preparations of male caregivers has been documented 26. However, hirsutism in these 
cases would be sudden and pronounced.  
When all the aforementioned disease conditions have been ruled out, a diagnosis 
of PCOS or idiopathic hirsutism (IH) should be considered. In 2003, the ASRM/ESHRE 
revised the diagnostic criteria for diagnosis of PCOS (Table 4) 27. 
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Table 4. Revised Diagnostic criteria for PCOS. Note: Thorough documentation of applied diagnostic criteria should be done(and 
described in research papers) for future evaluation.2003 Rotterdam PCOS consensus. Fertil Steril 2004 
In a Finish longitudinal study involving 196 women complaining of 
oligomenorrhea and/ or hirsutism, polycystic ovaries were found in 70.4% of women 
with both symptoms and in 18.4% of women with hirsutism compared with 18.2% of 
normal controls. 37.3% of the all women with either hirsutism or oligomenorrhea had 
polycystic ovaries, more than double the percentage in normal controls 28. Chronic an-
ovulation used to be a required criterion for PCOS. Consequently, eumenorrheic women 
with signs of androgen excess and no other disease process were diagnosed with IH. 
Studies have shown that even in eumenorrheic women with signs of androgen excess, 
PCOS may be present. Approximately 40% of eumenorrheic women are actually an-
ovulatory and have PCOS, not IH 1.  Hirsute women who claim to have regular periods 
should be evaluated further for ovulatory dysfunction. Azziz et al found that in a study  of 
228 women with minimal unwanted facial hair (mF-G of 1-5), one third of the women 
with regular menstrual cycles were round to be an-ovulatory after day 22-24 progesterone 
levels were  found to < 4ng/dl 1. 
From personal observation and anecdotal evidence, Nigerian women who have 
moved to the U.S.A complain of hirsutism mostly in the form of facial hair than the ones 
who live in Nigeria. This may be because of more awareness of facial hair in a culture 
where facial hair is considered unsightly. However, hair growth in a male pattern by a 
female is stigmatized in Nigeria as well, so bias is unlikely to be to cause of this 
- 19 - 
  
difference. Till date, many studies have been done to decipher the etiology of hirsutism. 
However, so far, no studies have examined the rates of hirsutism in genetically similar 
women who live in different environments. 
Abbreviations: AR androgen receptor, B.M.I Body Mass Index, CAH Classic Adrenal 
Hyperplasia, DHEAS Dihydroepiandrosterone Sulfate , DHEA Dihydoepiandrosterone, DHT 
Dihydrotestosterone, DM Diabetes Mellitus,  E2 Estradiol, FDA Food and Drug Administration, FSH 
Follicle Stimulating Hormone, HAIRAN HyperAndrogenic,  Insulin Resistant  Acanthosis Nigricans, HDL 
High Density Lipoprotein,  IGF-1 Insulin Like Growth Factor-1, GH Growth Hormone, LH Luteinizing 
hormone, mF-G modified Ferriman-Gallwey, NADPH Nicotinamide Adenine Dinucleotide PHosphate, 
NCAH Non Classical Adrenal Hyperplasia, PCOS PolyCystic Ovarian Syndrome, PSU PiloSebaceous 
Unit, T Testosterone, SHBG Sex Hormone Binding Globulin, TbA Trenbolone Acetate, TBOH trenbolone, 
WHR Waist-to-Hip ratio,  
 




Women living in the U.S.A are more likely to be hirsute than women living in 
Nigeria most likely due to environmental exposures. The null hypothesis is that location 
will not affect the rates of hirsutism of Nigerian woman living here or in Nigeria. 
 
 
 The specific aims of the study 
 The study aims to demonstrate that given a shared genetic heritage, 
environmental factors may play a larger role in the development of androgen excess 
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Methods 
The study was approved by the Human Investigations committee of The Yale 
University School of Medicine as HIC#0611001976. Subjects were recruited online by 
sending emails to webmasters of “listservs” or mailing lists for Nigerian students and 
professionals. These lists mostly serve as a forum for discussion and information for 
Nigerians who share a common academic, tribal, social or religious bond. To participate, 
subjects had to be: 
• Born in Nigeria of Nigerian parents 
• Live in the U.S.A or Nigeria 
• If in the U.S.A must have lived there for 3 yrs or more 
• Must be older than eighteen years of age 
Participants logged on to an independent online 
(http://www.freeonlinesurveys.com) site to complete a questionnaire. They scored six 
body parts: the upper lip, the chin, the chest, the upper abdomen , the lower abdomen and 
the thigh based on the following pictorial scale taken from Azziz et al: 1 
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Figure 6. Visual method of scoring hair growth in women, modified from the system originally reported by Ferriman and Gallwey in 
1961. Each of the nine body areas depicted is scored from 0 (absence of terminal hairs) to 4 (extensive terminal hair growth), and the 
scores in each area are summed for a total hair growth score. Hair growth scores of 6 to 8 or greater are generally considered to 
represent hirsutism. (Adapted with permission from Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: Implications, etiology, 
and management. Am J Obstet Gynecol 1981;140:815–30 Azziz. Hirsutism. Obstet Gynecol 2003 
Each participant also answered questions concerning her age, menstrual history 
(length of menstrual cycle, cycle regularity, and period length), height, weight, tribal 
origin, and use of hormonal medications. In addition, women in the U.S.A provided the 
length of time they had spent living in the U.S.A and the Nigerian residents indicated if 
they had ever lived in the U.S.A for more than 3 years at a stretch. A score of ≥ 6 was 
designated as a cut-off for hirsutism based on work done by Azziz et al. Statistical tests 
were performed to determine compare means in both locations. Sas® JMP program was 
used to calculate ANOVA to determine equivalence of the factors age, B.M.I, cycle and 
period length from the 2 locations. Chi2 tests were used to compare the factors hormone 
use and cycle regularity across both locations. Multivariate analysis in form of multiple 
regression and effect tests was used to determine independent predictors of hirsutism 
score. 
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Results 
A total of 186 women entered the study.  Four women were excluded from the 
final statistical analysis: one woman residing in Nigeria for a standing diagnosis of 
PCOS, and three women residing in the U.S.A cohort because they had not lived in the 
U.S.A for up to 3 years. Of the 183 left, 112 live in the U.S.A and 71 live in Nigeria.  
Four of the women living in Nigeria had spent between 4 and 11 years living in the 
U.S.A. Women taking the survey from the U.S.A had lived in the country for between 3 
and 33 years.  Mean age of all participants was 27.4 ± 6 (SEM 0.44, minimum 18, 
maximum 57) and B.M.I was 24.5± 5.1 (SEM 0.37, minimum 7, maximum 46).  23.32% 
of the women in the U.S.A and 12.5% of the women living in Nigeria had a score of 6 or 
more.  Tables 6 and 7 summarize the modified Ferriman- Gallwey scores and 
demographics of the subjects. Of overweight or obese women, 17 had modified 
Ferriman-Gallwey scores of 6 or greater. Of these, 23 (32%) live in Nigeria 48 (43%) live 






Below 18.5 Underweight 13 5 
18.5 – 24.9 Normal 55 52 
25.0 – 29.9 Overweight 21 30 
30.0 and Above Obese 11 13 
                                          Table 5. Distribution of weight categories in Nigeria and the U.S.A 
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score ± S.D S.E.M 
 Age 29.07 ± 4.92 0.58 0.002 26.32 ± 6.37 0.60 
 B.M.I 23.79 ± 5.26 0.62 0.13 24.95 ± 4.90 0.46 
Upper 
Lips 0.25 ± 0.50 0.06 0.006 0.47 ±  0.61 0.06 
Chin 0.32 ±0.67 0.08 0.003 0.71 ± 1.00 0.09 
Chest 0.20 ±0.43 0.05 0.2 0.27 ± 0.63 0.06 
Upper 
Abdomen 0.42 ±0.71 0.08 0.15 0.54 ± 0.79 0.07 
Lower 
Abdomen 1.39 ±1.03 0.12 0.15 1.56 ±1.11 0.10 










G score 3.10 ±2.77 0.33 0.005 4.32 ± 3.34 0.32 
Period 
Length 












(days) 28.11 ±3.17 0.38 0.63 27.83 ± 4.26 0.40 
Table 6. Summary of descriptive statistics classified by location. S.D = Standard Deviation, S.E.M = Standard Error of  Mean, mF-G 

























































                               Table 7. Characteristics of survey participants by location 
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Multiple Regression and Effect Tests 
Effect of Individual factors 







Tribe 2 2 64.64014 3.2774 0.04 
Location 1 1 64.97742 6.6268 0.0108 
Age 1 1 56.52342 5.7373 0.0176 
B.M.I 1 1 4.593591 0.4531 0.5017 
Cycle 
regularity 1 1 0.158678 0.0156 0.9007 
Hormone 
use 1 1 56.04753 5.6875 0.0181 
                           Table 8. Effects of  tribe, location, age, B.M.I, cycle  regularity and hormone use as individual factors.  
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Only tribe, location, age and hormone use had significant effects on total score 
when cosidered as individual predictive factors. However in both locations, the number 
of women on hormonal medications were few (Table 7) and comparable. Time spent in 
the U.S.A was not an independent predictor of total score (P= 0.388) for the women in 
both location. The women on hormonal medications, in this case mostly different types of 
oral contraceptives, had lower average total scores than women who were not taking 
hormonal medications.  
The median scores for women 
not on hormonal medications 
was 3, the maximum score was 
16 and 25% of them had total 
scores that were 6 or greater. 
Mean was 4.02 ± 3.2 (S.E.M= 
0.25) 
On the other hand, women who were on hormonal 
medications, though few, had a median score of 1, and 
less than 10% had a total score of 6 or more. Mean 







Figure 8. Total mF-G score distribution of women who denied hormone use. 
Figure 9. Total mF-G score distribution of women 
on hormonal medications. 



















                     Figure10.  Correlation between age, B.M.I and total scores of the women residing in Nigeria 
In Nigeria, there was a positive correlation between mF-G score and B.M.I but a negative 
correlation of total score with age. (Figure 10). With women residing in the U.S.A, there 
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Figure 11. Correlation between age, B.M.I and total scores of  women living  in Nigeria 
              




The following tables show the results of the multiple regression model when 
several variables are evaluated simultaneously. 
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Source Nparm DF 
Sum of 
Squares F Ratio 
Prob > 
F 
Age 1 1 35.837531 3.9409 0.0487 
Hormones 1 1 74.487406 8.191 0.0047 
Tribe 2 2 60.933223 3.3503 0.0373 
Location 1 1 50.26592 5.5275 0.0198 
Table 9a. Effect tests of the most significant factors.  
Hormone use was the most significant predictive factor followed by location, tribe 
and age respectively. 
 
Source Nparm DF 
Sum of 
Squares F Ratio 
Prob > 
F 
Age 1 1 29.635867 3.1324 0.0785 
Tribe 2 2 56.319206 2.9763 0.0535 
Location 1 1 43.079331 4.5533 0.0342 
Table 9b. Effect tests of  age, tribe and location 
 
Source Nparm DF 
Sum of 
Squares F Ratio 
Prob > 
F 
Age 1 1 25.50264 2.7933 0.0964 
Tribe 2 2 63.163515 3.4592 0.0336 
Location 1 1 52.988156 5.8039 0.017 
Hormones 1 1 73.172233 8.0146 0.0052 
B.M.I 1 1 2.759328 0.3022 0.5832 
Table 9c. Effect tests of age, tribe, location, hormone use and B.M.I 
 




Source Nparm DF 
Sum of 
Squares F Ratio 
Prob > 
F 
Oligomennorhea 1 1 0.1269275 0.0125 0.9113 
B.M.I 1 1 4.5618403 0.4475 0.5044 
 Table 9d. Effects of cycle regularity and B.M.I 
 
 
Source Nparm DF 
Sum of 
Squares F Ration Prob >F 
B.M.I 1 1 7.61066601 0.803427 0.371288 
Age 1 1 13.0724578 1.380006 0.241678 
Location 1 1 53.1468204 5.610494 0.018931 
Tribe 2 2 63.0439422 3.327647 0.038135 
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Figure 12. Distribution of mF-G scores of women living in Nigeria 
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Figure 13. Distribution of mF-G scores of women living in the U.S.A 
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Discussion 
The results show a significant difference in the rates of hirsutism between 
genetically similar women in dissimilar environments after correcting for age and B.M.I.  
There are many possible reasons for the observed difference. 
The women from the U.S.A may have frankly higher levels of androgen, more 
sensitive ARs or lower rates of degradation/ clearance of the principal androgens. It is 
unlikely that the women residing in the U.S.A developed a different type of 5α- reductase 
isozyme  on migrating to the U.S.A, however, is it possible that they may  have increased 
levels of 5α- reductase metabolites  due to other mechanisms, for example through 
environmental/toxicological effects such as diet or through topical cosmetics. The 
difference may also be caused to increased steroidogenesis in the adrenals possibly in 
relation to stress. 
As for the diseases that constitute the differential diagnosis of hirsutism, it is 
possible that some of the subjects in this study have NCAH. However, with the low 
incidence in the black population and the relatively small number of participants in the 
study, this likelihood is very low. There is low likelihood of HAIRAN syndrome as the  
B.M.I of the women in Nigeria did not significantly differ from the women that live in 
the U.S.A. It was expected that the women in the U.S.A would have a higher average 
B.M.I because women who live in Nigeria would be expected to be more physically 
active than women residing in the U.S.A. Perhaps, due to the method employed in 
collecting data, we have selected for a certain type or class of woman. The average 
- 35 - 
  
participant in Nigeria lives in the city. She has a degree from a tertiary institution, has the 
financial means to afford the internet, or works for a company (usually a multi-national) 
that can provide internet access at work and probably works at a sedentary (office) job.  
Furthermore the level of physical activity in urban areas in Nigeria has decreased 
considerably because many people can now afford automobiles. Not only that, almost all 
places are now accessible via ‘okada’ which are motor scooters used for transport. The 
average person does not have to walk as much. Also, the women residing in Nigeria who 
took our study are also probably able to afford food with higher fat content, including 
foods from the fast food industry, one of the fastest growing segments of industry in 
Nigeria today.   
As for  the possibility that the women residing in the U.S.A are exposed to 
exogenous androgens, there is the occasional athletic woman who wants to improve lean 
muscle mass by body building and anabolic steroid use, but I doubt any of the women in 
this study fits that profile. The possibility of topical exposure from male partners using 
topical androgens exists since the U.S.A offers easier access to topical androgens via the 
internet and a more reliable postal system.  Also related to topical exposure are 
hormonally active compounds in topical preparations and personal care cosmetics. A 
common practice among people of African descent is skin lightening (otherwise known 
as ‘bleaching’) using mostly topical glucocorticoids and/or hydroquinone. One 
documented side effect of skin lightening is hypertrichosis 32 amongst many more serious 
ones (e.g. cushingnoid features). This could have been mistaken by some of our subjects 
for hirsutism. There is no way to know which of the women bleach, however there seems 
to be no reason why Nigerian women living in the U.S.A may be more likely to ‘bleach’ 
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than the women in Nigeria. Besides, the women in the study are most likely well 
educated and are likely to know the deleterious side effects of ‘bleaching’.   
The most plausible source for steroid ingestion would be as part of a regular diet. 
Environmental androgens can act as precursors of naturally occurring biologically active 
androgens testosterone (T) and dihydrotestosterone (DHT) or result from anabolic steroid 
use in the livestock industry 30.  
Nigerians, by culture and upbringing are carnivores. It’s hard to find a Nigerian 
vegetarian. Most Nigerians consume beef on a daily basis. Poultry, goats, sheep and 
turkey are mostly reserved for special occasions. However, with the rise of the fast food 
industry, poultry is becoming commonplace too. Meat is generally more costly than fresh 
vegetables; however, the average Nigerian family finds it more affordable to eat beef, not 
chicken. Meat constitutes a small part of the diet and is usually eaten at lunch and very 
rarely at dinner. That is to say, even though meat is consumed daily, it is consumed in 
small pieces/portions at a time. Frozen fish, which is much cheaper than fresh, especially 
mackerel (known as ‘the corpse of Lagos’) is also a regular part of many diets. Breakfast 
typically consists of a source of starch: fermented corn or millet gruel, bread, or yam, 
eaten with fried bean cakes, steamed ground beans (sort of like tamales but made of 
beans) or a tomato based sauce. It rarely includes meat, but may have some fish. The 
amount of meat eaten with every meal is considerably smaller than the portion of meat 
included with meals in the U.S.A. Butter and other dairy products such as cheese are 
consumed mostly by people of high socioeconomic class and are not a consistent part of 
the middle class diet. The exception is in Northern Nigeria where Hausa and Fulani 
women make curds from cow milk and drink fresh cow milk from their herds. The 
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change in diet when a woman moves from Nigeria to the U.S.A is therefore quite 
significant. She will consume more saturated fat, less fiber, more meat, more dairy 
products and a significantly larger portion size. 
An Italian randomized case-control study on post menopausal women, the 
DIANA study, examined the effects of change in diet on the hormonal profile of 312 
women with high plasma levels of T. The intervention group reduced their intake of 
meat, eggs and dairy products; increased their consumption of soy based products, 
substituted whole grain products for refined carbohydrates and reduced their intake of 
cooking fat and salt. The study found that the interventional group significantly reduced 
their weight, B.M.I, WHR, T, E2 and increased their SHBG compared to controls. The 
changes were no longer significant after correcting for weight change, which showed that 
the observed differences may be due to weight loss 46. As such, changing diets may as 
well explain some of the difference observed in our study. 
In the U.S.A the use of natural and synthetic hormones is permitted in livestock, 
but not in Nigeria. Though poultry farming has been modernized in many areas, cattle-
rearing is still practiced mainly by the Fulani tribe in northern Nigeria as it has been done 
for centuries31 
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         Figure 14. Red Fulani (Rahaji) cattle grazing on open land, green grass; treeless hills behind.  Mambilla  Plateau, Nigeria. 
Copyright and Credit: www.tropix.co.uk / D. Davis 
The Fulani are nomadic cattle herders, moving often to find pasture and water for 
their herds. Many live agrarian and subsistence lives; they do not have the financial 
means, nor the technical knowhow to administer hormones. Market ready cattle are 
transported live (by road) all over the country for slaughter and sale in regional meat 
markets. 
    The first steroid hormone used after approval by FDA in beef and sheep was 
diethylstilbebestrol (DES) in 1954. It was banned in 1979 due to its carcinogenic 
potential.  Since 1956, a number of synthetic and natural hormones have been approved 
for use including estradiol benzoate (EB) in 1956, melengestrol acetate in 1968, zeranol 
in 1969, trenbolone acetate in 1987, and bovine somatotropin in 1993 (for lactating 
cows). Testosterone was first use in concert with EB in 1958 32. Hormones now 
commonly used in North America for raising livestock include synthetic steroids such as 
zeranol, trenbolone acetate, and melengestrol acetate and  the naturally occurring ones 
such as estradiol 17β, testosterone,  progesterone and bovine growth hormone 33.   The 
effects these steroids have on human consumers have been debated for a long time.  In 
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fact, invoking the precautionary principle, the European Union banned both the use of 
growth promoting hormones in meat and the importation of hormone treated meat from 
the U.S.A and Canada32. 
The evidence for interference of normal reproductive processes by xenobiotics 
used in raising livestock is not well established. Trenbolone acetate (TbA), a semi- 
synthetic androgen precursor, widely used in raising livestock to promote increase in 
muscle mass 34, 35 is also a potent anti-glucocorticoid and displays a high affinity for the 
progestin receptor in pigs 30. The anabolic effect of TbA is 8-10 times stronger than 
testosterone 36,37. It is hydrolyzed into 17α- and 17β trenbolone (TBOH) in vitro.  17β 
trenbolone is about as potent if not more potent than DHT in acting as an AR agonist 36. 
The anabolic potency of the 17α isomer is only about 5% of the 17β isomer. Studies have 
shown that these chemicals along with other pharmaceuticals in groundwater runoff or 
effluents from feedlots disrupt endocrine function in the wild 30. In a study to determine 
the levels of TbA in the environment after use as growth promoters in livestock, the 17β 
isomer was found to have a half-life of 257 in liquid manure. Compared to liquid manure, 
the concentration of both isomers were 5-70 times higher in solid dung before storage 37. 
In tissues, TbA metabolites bind with remarkable affinity to proteins and undergo biliary 
excretion.  90% of the TbA in implants given to heifers in one study could not be 
extracted with commonly used organic solvents suggesting that it was either water 
soluble or insoluble tissue-bound residue 38. 
Trenbolone (TBOH)  resulting from the hydrolysis of TbA is the main metabolite 
found in meat and organs of treated cattle. Unchanged TbA can only be detected in fatty 
tissue 35. The levels of 17βTbOH in uncooked bovine tissue in ascending order are 
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muscle, liver, kidney, and fat.  Unlike T, 17β-TbOH cannot be aromatized to estrogen 
and is not reduced by 5α reductase 33. This is significant because non-muscular parts of 
the animal are used in many Nigerian delicacies, so the average Nigerian in the U.S.A 
may consume more offal, and by so doing, more TbA, than most.  
Safe concentrations of T and 17β-TbOH in human beings was determined by the 
USDA to be  an exposure less than 1% of the daily synthesis in pre-pubertal human 
females and males respectively . For 17β-TbOH this translates to a daily consumption of 
102ng 33.  Trenbolone residues in meat from implanted cattle range from 0.01 to 0.3 
mg/kg in most cases 39.  The level of TbA detected in livestock tissue is inversely 
proportional to the number of days, post implantation, preceding the slaughter of the 
animal. 
Since TbA can accumulate in fatty tissue unchanged, and its metabolite 17β-
TbOH has a half life of about 8 months in the environment, it is possible that women in 
the U.S.A not only ingest TbA in meat, but also from the environment (in water). With 
such environmentally stable active metabolites- detectable for almost 8 months - and the 
ability of fat to serve as a TbA reservoir, there is the possibility of an accumulative effect. 
It would not be too far-fetched to suggest that women who consume meats so treated are 
at risk of accumulating increasingly physiologically significant amounts of this potent 
metabolite in fat especially  since they will likely gain weight in the U.S.A. This could be 
likened to an endogenous TbA ‘patch’ steadily releasing low levels of 17β-TBOH in the 
women who live in the U.S.A.  
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One argument against this hypothesis is the difference in routes of administration 
and clearance in humans and other mammals. In human meat ingestion, the route is oral 
and may subject the hormone to break- down by digestive enzymes; whereas, TbA in 
livestock is administered subcutaneously. One study showed that a dose of radioactively 
labeled trenbolone subcutaneously administered to a human volunteer was mostly (63%) 
excreted in the urine during the first 72 hours, with over half of the radioactivity present 
in glucuronides 39, whereas, excretion in cows and rats are primarily biliary and fecal.  
The significance of these findings extends beyond mere aesthetics. 
Hyperandrogenic women tend to cluster risk factors for reproductive site neoplasia 44.  
Androgen excess has been shown to induce polycystic ovaries in female to male 
transsexuals45. Apart from decreased fertility, there is increasing evidence that 
hyperandrogenic patients may be at higher risk of metabolic and cardiovascular disease. 
PCOS, a disease characterized by excess androgen, is associated with dyslipidemia 
(generally reduced HDL) and increased C-reactive protein 29. Hyperandrogenism is 
associated with elevated thromboxane B2 and A2 levels leading to the potential for 
increased platelet aggregation and vasoconstriction 44. Lastly, hyperandrogenic women 
are predisposed to the accumulation of visceral fat typical of men.  In a study of 10, non-
obese, female-to-male transsexuals that had been ovariectomized receiving 250mg/day 
testosterone treatment. It was found that after about 3 years and in as little as 1 year after 
initiation of treatment, the women underwent a redistribution of fat depots with most of 
the deposition in the abdominal area even though muscle mass increased peripherally 40. 
In another study, a case-control study comparing normal weight (B.M.I < 25), 
premenopausal, infertile  women with either anorexia nervosa, primary infertility,  or 
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PCOS with normal controls, women with PCOS showed the highest average serum levels 
of T and DHEAS. They also had average FDI (fat distribution index = upper body fat 
mass (kg)/lower body fat mass (kg)) >1 compared to women in other groups who had 
average FDI < 1(P < 0.03) 42. Increased visceral fat may predispose these women to the 
development of DM II 44.   
Some researchers have postulated that obesity results in increasing levels of 
circulating androgens and not vice versa 43. Carmina provides an example of a patient 
who gained weight due to a stressful life event, increased her B.M.I by almost 6 and 
converted from ovulatory PCOS to classic PCOS 29.  Women in our study residing in the 
U.S.A may have conditions that fit into the PCOS spectrum such as ovulatory PCOS. 
Women with ovulatory PCOS do not have decreased fertility like in classic PCOS but are 
as likely to present with hirsutism and hyperandrogenemia as those with the classic 
variant. However, they are more likely to be of normal body weight and have regular 
menstrual cycles; and their serum insulin and glucose profile and B.M.I are intermediate 
between that of idiopathic hirsutism controls and classic PCOS 29. As such, is it possible 
that the development of PCOS represents a continuum. The condition may start with 
idiopathic hirsutism, and due to environmental and genetic factors, progress to classic 
PCOS. It is possible that women already genetically predisposed to PCOS, who change 
environments from one where food is relatively scarce or at least consumed in 
moderation to one where food is more plentiful, cheaper and more calorific, combined 
with less likelihood of remaining physically active, may just be in the environmental 
milieu necessary to push them along the continuum. However from our results, being 
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both overweight and oligomenorrheic did not seem to be significant in determining mF-G 
score (Table 9d). 
Carmina’s findings also raise the possibility that stress may play a significant role 
in the observed differences. As discussed earlier, adrenal steroidogenesis may play a role 
in the development of hirsutism. It is not uncommon in Nigerian gatherings to hear 
people talk about how much more under stress they feel in the U.S.A than when they 
were in Nigeria. Many Nigerians here live relatively more socially isolated lives than 
they lived in Nigeria where family ties and societal connections are very close- knit. They 
also probably work longer hours and may not take care of themselves as well as they 
would have given more time on their hands.  Chronic stress has been linked to both 
obesity and increased visceral fat stores and may play a part in the development of DM 
II. In chronically stressed individuals, hypercortisolemia results in increasing levels of 
LH and FSH leading to increasing levels of sex steroids, increasing central obesity and a 
host of other endocrine responses 44 (see figure 15).   
This study has many limitations: Since the participants self-score themselves, 
their evaluations may have been biased. However, directly observing the women may not 
have been more productive because women use a variety of hair removal techniques. 
Many lifestyle factors such as smoking, physical activities and diet were not examined. 
The women were not asked about acne and alopecia, two other manifestations of 
androgen excess Furthermore, the total score is largely dependent on what parts of the 
body are scored2. In Nigerian women according to our study, the scores from the upper 
abdomen were consistently the highest in both locations. In the Hassa study of Turkish 
women, the thigh was the highest contributor to total score2. B.M.I may not have been 
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sufficient to determine the fat distribution of the participating women; a waist-to-hip ratio 
may also have been helpful to determine cardiovascular risk. So would levels of LH, FSH 
and androgens. To find out the effects of the use of anabolic steroids in livestock, 
Nigerian immigrants in the UK, where use of anabolic growth aids in livestock is 
prohibited, could have been included. Ultrasound of the ovaries may have helped in 
ruling out PCOS and clarifying the reasons for the differences we observed. 
In summary, there are many plausible reasons why genetically similar women in 
these two different environments exhibit a differential rate of hirsutism. Further research 
would be necessary to identify the most likely reasons. 
  
Figure 15. Schematic showing that stress may affect the secretion of sex hormones and central obesity. Schematic representation of 
the detrimental effects of chronic stress on adipose tissue, bone, and muscle metabolism, that may lead to clinical manifestations of the 
metabolic syndrome. Chronic HPA activation favors visceral obesity and lean body (muscle and bone) mass reduction. Hypersecretion 
of TNF-_ and IL-6 is proportional to the accumulated adipose mass and induces the production of acute-phase reactants by the liver. 
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Reciprocally, the proinflammatory cytokines further stimulate the HPA axis activation,thus, forming a deleterious vicious cycle. CRH 
= corticotropin-releasing hormone; ACTH = adrenocorticotropic hormone; LH = luteinizing hormone; FSH = folliclestimulating 
hormone; GH = growth hormone; IGF-1 = insulin-like growth factor-1; TNF-_ = tumor necrosis factor-_; IL-6 = interleukin-6; CRP = 
C-reactive protein. Stimulation is represented by solid lines and inhibition by dashed lines. Ann. N.Y. Acad. Sci. 1083: 77–110 
(2006). C_ 2006 New York Academy of Sciences. 
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Conclusion 
The regulation of hair growth in the human is both a fascinating and complex 
process. The results of this study suggest that changes in environmental factors of the 
women who live in the U.S.A may be responsible for observed differences in rates of 
hirsutism between Nigerian women in the U.S.A and the ones living in Nigeria. Having 
limited the possible contribution of genetic factors, environmental or lifestyle factors 
remain the most likely causes.   Identifying the etiology of hirsutism involves ruling out 
several disease states involved with the regulation of sex hormones, adrenal function, and 
thyroid function. The most likely etiology epidemiologically is hyperandrogenism. The 
observed difference may not be trivial because of the association of hyperandrogenism 
with increased risk of cardiovascular diseases and neoplastic risk. The safety of the use of 
anabolic hormones in livestock needs to be re-examined as they may represent a reservoir 
of exogenous androgen. Stress is a factor in the development of obesity, 
hypercortisolemia, and possibly PCOS spectrum disorders.  The observed changes may 
also be attributable to increased levels of stress. 
 It would be fascinating to compare the rates of PCOS in vegetarians to omnivores 
or the effect of switching from an omnivorous to a carnivorous diet on the progression of 
PCOS.  
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